Pay in 4 interest-free payments of $7.38 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
It is a non-selective agonist of MC1R, MC3R, MC4R, and MC5R with preferential activity at MC3R/MC4R
If youre prescribing GLP-1s, make sure youre doing it legally
You lose the discounted price for that fill
However, it is typically prescribed to those with a Body Mass Index (BMI) of 30 or higher, as well as for individuals who have a BMI of 27 or above who also have weight-related conditions
Approved in November 2023, Zepbound is a dual agonist targeting both GLP-1 and GIP receptors
US$ 24.04
US$ 20.80
US$ 22.60
/sc-assets/prd/practices/cdcd65da-a892-465a-aa2c-48d5c1f8134f/Tirzepatide%20vial.png)
US$ 22.34
US$ 20.27
